Northumberland Health Authority guidelines

Patient advice leaflets

Members of the Northumberland Working Group on Weight Loss

While we have endeavoured to ensure that all information provided on doses, licensed indications, interactions and contra-indications arc correct at the time of going to press, we recommend that readers always consult the most recent APBI Data sheet compendium for detailed guidance.

This document will be reviewed during 2001.


References

  1. Brac, GA, Lancet 1998; 352: 160-161
  2. Management of Obesity - An Overview - UK Drug Information Pharmacists Group in conjunction with the National Prescribing Centre, September 1998.
  3. Obesity: the report of the British Nutrition Foundation Task Force, British Nutrition Foundation, Blackwell Science 1999.
  4. Why and how should adults lose weight?, Drug and Therapeutics Bulletin, December 1998; 36(12): 89-93
  5. The prevention and treatment of obesity, Effective Healthcare, April 1997; 3(2): 1-12
  6. Clinical guidelines on the identification, evaluation and treatment of overweight and treatment of overweight and obesity in adult: Executive Summary, Expert panel on the Identification, Evaluation and Treatment of Obesity in Adult. American Journal of Clinical Nutrition 1998: Volume 68; page 899-917.
  7. Clinical Management of overweight and obese patients, Royal College of Physicians, December 1998.
  8. Personal communication, servier labs ltd September 1997
  9. National Prescribing Centre, New Drugs in Clinical Development, Sibutramine monograph number 3/98/1 0, November 1998
  10. Personal communication, Regional Drug and Therapeutics Centre Nov 1999.